Premium Catering (Holdings) Limited (PC)

NASDAQ: PC · Real-Time Price · USD

7.76

-0.08 (-1.02%)

At close: Aug 1, 2025, 4:00 PM

7.75

-0.01 (-0.13%)

After-hours: Aug 1, 2025, 7:21 PM EDT

Regulus Therapeutics Income Statement

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Revenue	4.57	5.16	5.21	5.27
Revenue Growth (YoY)	-15.99%	-0.96%	-1.00%	-
Cost of Revenue	3.88	4.49	4.22	4.1
Gross Profit	0.69	0.68	1	1.16
Selling, General & Admin	3.22	2.16	1.37	0.95
Other Operating Expenses	-	-	-	0.02
Operating Expenses	3.22	2.16	1.37	0.97
Operating Income	-2.54	-1.49	-0.38	0.2
Interest Expense	-0.14	-0.17	-0.13	-0.08
Other Non Operating Income (Expenses)	0.21	0.13	0.08	0.11
EBT Excluding Unusual Items	-2.46	-1.52	-0.44	0.23
Gain (Loss) on Sale of Assets	0.04	0.04	-	0.17
Asset Writedown	-	-	-0.02	-
Other Unusual Items	0.01	0.02	0.01	0.15
Pretax Income	-2.41	-1.46	-0.44	0.55
Income Tax Expense	0	0	-	0.03
Net Income	-2.42	-1.47	-0.44	0.51
Net Income to Common	-2.42	-1.47	-0.44	0.51
Shares Outstanding (Basic)	2	2	2	2
Shares Outstanding (Diluted)	2	2	2	2
EPS (Basic)	-1.04	-0.66	-0.20	0.23
EPS (Diluted)	-1.04	-0.66	-0.20	0.23
Free Cash Flow	-4.96	0.59	1.29	-1.48
Free Cash Flow Per Share	-2.14	0.27	0.58	-0.67
Gross Margin	15.05%	13.08%	19.10%	22.10%
Operating Margin	-55.54%	-28.79%	-7.26%	3.72%
Profit Margin	-52.90%	-28.40%	-8.47%	9.75%
Free Cash Flow Margin	-108.61%	11.52%	24.74%	-28.06%
EBITDA	-2.45	-1.39	-0.26	0.29
EBITDA Margin	-53.57%	-26.91%	-5.00%	5.48%
D&A For EBITDA	0.09	0.1	0.12	0.09
EBIT	-2.54	-1.49	-0.38	0.2
EBIT Margin	-55.54%	-28.79%	-7.26%	3.72%
Effective Tax Rate	-	-	-	6.21%

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q